Multiple Sclerosis Therapeutics
Latest Publications

TOTAL DOCUMENTS

50

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By CRC Press

9780429214943

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Use of magnetic resonance imaging in clinical management of multiple sclerosis Myla D Goldman and Lael A Stone

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-52 ◽

2007 ◽

pp. 793-804

Keyword(s):

Magnetic Resonance Imaging ◽

Multiple Sclerosis ◽

Magnetic Resonance ◽

Clinical Management ◽

Resonance Imaging

Download Full-text

Use of mitoxantrone to treat multiple sclerosis

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-33 ◽

2007 ◽

pp. 489-512 ◽

Cited By ~ 2

Keyword(s):

Multiple Sclerosis

Download Full-text

Glatiramer acetate as therapy for multiple sclerosis

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-32 ◽

2007 ◽

pp. 463-488

Keyword(s):

Multiple Sclerosis ◽

Glatiramer Acetate

Download Full-text

Interferons in secondary progressive multiple sclerosis Ruth Ann Marrie and Jeffrey A Cohen

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-30 ◽

2007 ◽

pp. 425-440 ◽

Cited By ~ 1

Keyword(s):

Multiple Sclerosis ◽

Progressive Multiple Sclerosis ◽

Secondary Progressive Multiple Sclerosis ◽

Secondary Progressive

Download Full-text

Interferons in relapsing–remitting multiple sclerosis

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-29 ◽

2007 ◽

pp. 405-424

Keyword(s):

Multiple Sclerosis ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Clinical trial logistics Steven R Schwid

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-23 ◽

2007 ◽

pp. 341-350

Keyword(s):

Clinical Trial

Download Full-text

Selection and interpretation of end-points in multiple sclerosis clinical trials

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-22 ◽

2007 ◽

pp. 327-340

Keyword(s):

Multiple Sclerosis ◽

Clinical Trials ◽

End Points

Download Full-text

The process of drug development and approval in the United States, the European Union and Canada

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-21 ◽

2007 ◽

pp. 311-326

Keyword(s):

United States ◽

European Union ◽

Drug Development ◽

The United States ◽

The European Union

Download Full-text

Measures of gadolinium enhancement, T1 black holes and T2-hyperintense lesions on magnetic resonance imaging in multiple sclerosis

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-13 ◽

2007 ◽

pp. 145-174

Keyword(s):

Magnetic Resonance Imaging ◽

Multiple Sclerosis ◽

Black Holes ◽

Magnetic Resonance ◽

Resonance Imaging ◽

Gadolinium Enhancement

Download Full-text

Health-related quality of life assessment in multiple sclerosis

Multiple Sclerosis Therapeutics ◽

10.3109/9780203012055-12 ◽

2007 ◽

pp. 133-144 ◽

Cited By ~ 2

Keyword(s):

Quality Of Life ◽

Multiple Sclerosis ◽

Life Assessment ◽

Health Related Quality ◽

Quality Of Life Assessment ◽

Related Quality ◽

Health Related

Download Full-text